Blog 3: The MGO Manuka Honey Advantage
- Kerry Paul
- Jun 9
- 4 min read
Updated: Jun 30
JOURNEY 3 - SERIES 3 - BLOG 3 - A PART OF 4 BLOGS IN SERIES 3 - Reading time: 4 Mins
First-Mover Advantage and Industry Transformation
One of Kerry Paul’s most significant strategic decisions was openly promoting the MGO system across the industry rather than keeping the discovery exclusive. Initially, other industry participants resisted the change, preferring older grading systems such as UMF and NPA. This case study highlights the international growth of Manuka Honey. The journey also reflects the realities faced by many New Zealand start-up businesses. These lessons provide valuable insights for New Zealand entrepreneurs. The experience demonstrates the challenges and opportunities involved in Building a Global business from New Zealand.
However, as consumer demand for scientific transparency increased, competitors were eventually forced to adopt MGO testing themselves. Within only a few years, MGO concentration became the dominant global standard for explaining manuka honey’s antibacterial activity.
This shift permanently changed the competitive dynamics of the industry.
Manuka Health benefited enormously from first-mover advantage because the company became strongly associated with scientific leadership, credibility, and innovation.
Transforming Demand Through Science and Branding
Kerry Paul’s broader insight was recognising that consumers were increasingly seeking natural products supported by evidence-based science. Rather than positioning manuka honey purely as a traditional food product, he positioned it within the rapidly growing global natural healthcare and wellness sector.
This strategic repositioning transformed demand because it:
Expanded the potential customer base
Elevated product value perception
Increased international consumer trust
Created strong product differentiation
Opened entirely new health and wellness applications
The result was not simply the growth of one company, but the creation of an entirely new global premium natural health category centred around New Zealand manuka honey.
How Science Changed Consumer Trust
One of the biggest drivers of industry growth was the dramatic increase in consumer confidence created by scientific validation.
Consumers increasingly wanted natural health products supported by measurable evidence rather than traditional claims alone. MGO provided exactly that.
The discovery allowed companies such as Manuka Health to market manuka honey according to measurable methylglyoxal concentration rather than abstract antibacterial ratings.
This scientific transparency appealed strongly to:
Health-conscious consumers
Medical practitioners
Scientists and researchers
Premium wellness retailers
MGO concentration became easy to understand:
Higher MGO = higher antibacterial activity
Consumers could compare products directly
Retailers could justify premium pricing
Scientists could validate claims more easily
The industry suddenly had a clear scientific story capable of supporting rapid international expansion.
The Role of Manuka Health in Commercialising MGO
A major factor in accelerating global demand was the commercialisation strategy implemented by Manuka Health and its founder, Kerry Paul.
In 2007, Manuka Health publicly announced the discovery of methylglyoxal and partnered with Professor Henle’s research team. In 2008, the company launched the MGO grading system internationally across 45 export markets.
This represented a major disruptive innovation within the industry because it replaced vague antibacterial terminology with precise measurable science.
According to Kerry Paul’s account:
“Scientists understood methylglyoxal, igniting a flood of publications showing the activity of the compound. As a result, sales for manuka honey grew exponentially.”
The MGO system effectively repositioned manuka honey into the premium natural healthcare category.
Why the Discovery Triggered Explosive Industry Growth
Several factors combined to create rapid global expansion following the discovery of methylglyoxal.
1. Scientific Credibility
The industry finally possessed strong scientific evidence explaining why manuka honey was unique. This dramatically increased acceptance among researchers, retailers, and educated consumers.
2. Premium Product Positioning
MGO allowed companies to market manuka honey as a highly differentiated premium natural healthcare product rather than simply another honey variety.
3. Consumer Simplicity
Consumers could now easily understand product strength using MGO numbers. This simplified marketing and strengthened purchasing confidence.
4. Media and Scientific Attention
The discovery generated significant scientific interest worldwide, resulting in a large increase in published research around manuka honey’s antibacterial, anti-inflammatory, and wound-healing properties.
5. Expansion into New Health Categories
Scientific credibility opened opportunities beyond traditional honey sales, including:
Medical wound-care products
Skincare products
Lozenges and supplements
Bioactive delivery systems
Pharmaceutical-related applications
This significantly increased the value potential of manuka honey.
6. Global Wellness Trends
The discovery coincided with rapidly growing international demand for natural health products, functional foods, and evidence-based wellness products. Manuka honey became perfectly positioned within this trend.
Industry-Wide Transformation
The discovery of methylglyoxal did not simply grow one company — it transformed the entire global manuka honey industry.
Within only a few years:
MGO testing became an international industry standard
Competitors were forced to adopt MGO labelling systems
Premium pricing increased dramatically
International exports surged
Scientific research expanded rapidly
Global awareness exploded
The commercial value of the industry increased enormously. By 2015, New Zealand honey exports had reached record levels, driven largely by manuka honey demand.
Until 2007, the New Zealand Manuka honey industry struggled to explain its product’s special qualities. The discovery of MGO provided the missing link, propelling Manuka honey into the spotlight and driving a surge in global sales—from USD 25 million in 2005 to USD 325 million by 2020. This breakthrough not only justified its premium price but also established New Zealand as the world leader in Manuka honey production.
The industry evolved from a relatively modest New Zealand agricultural sector into a globally recognised premium wellness category worth hundreds of millions of dollars annually.
Conclusion
Kerry Paul and Manuka Health transformed the global demand for manuka honey by combining scientific discovery, disruptive innovation, premium branding, and international market development. Through the identification and commercialisation of methylglyoxal (MGO), the company gave scientific credibility to manuka honey and fundamentally changed how the product was understood, marketed, and valued worldwide.
The company’s success demonstrated how a New Zealand business could create a globally recognised premium consumer brand by integrating natural advantages with science, innovation, and strategic execution.
To continue reading Series 3 we invite you to join us:
Building a Successful Business
$40
Free Shipping within New Zealand
For international shipping enquiries please contact: kerryjpaul@gmail.com
Comments